Good info @dybsie..... the AC8 trials identified the superiority of Neuvis over oils and Sativex, the benchmark spray formulation that has dominated the market for 20 years wherever its been available.
The key difference here is that oils can be injected by abusers (over my years working in Alcohol and other drug dependency, I've known some people who have injected cannabis oils - nasty scarring and potential for horrendous ulcers, but there it is) and Sativex too can be liable to abuse. Neuvis formulation provides a true medication that (hopefully) does not have the same risk of abuse.
Due to this aspect of Neuvis it should be a preferred option for prescribers. This is the substantive difference that creates the moat.
AC8 Price at posting:
14.3¢ Sentiment: Buy Disclosure: Held
(20min delay)